1200TiP Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC) von Orer, H.S., Nomak, G., Oksuzoglu, B., Senturk, R., Eralp, Y., Yumuk, F., Nomak, H., Sanyal, R.

Volltext

100P RS-0139, a novel tumor-targeted delivery of docetaxel, with potent anti-tumor activity in a broad spectrum of tumor cell lines and xenograft models von Nomak, G., Karacivi, M., Kutlu Ozkaya, S., Valeria, U., Sumer Bolu, B., Karatas, T., Catapano, C.V., Orer, H.S., Sanyal, A., Sanyal, R.

Volltext

Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat von Merahi, N, Orer, H S, Laporte, A M, Gozlan, H, Hamon, M, Laguzzi, R

Volltext

Baroreceptor reflex inhibition induced by the stimulation of serotonin 3 receptors in the nucleus tractus solitarius of the rat von Merahi, N., Orer, H.S., Laporte, A.-M., Gozlan, H., Hamon, M., Laguzzi, R.

Volltext